Reports
Reports
Sale
The global smart pills market size attained a value of about USD 1.07 billion in 2023, driven by the growing number of people suffering from gastrointestinal disorders. The market is further expected to grow at a CAGR of 16.2% during the forecast period of 2024-2032 to reach a value of nearly USD 4.13 billion by 2032, driven by the increasing prevalence of addiction across the globe.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America is one of the leading markets in the world and is expected to grow significantly during the forecast period. The demand for smart pills in North America is mainly driven by a growing geriatric population, rising disease complexity, strong healthcare infrastructure, the involvement of key companies, and an increasing trend towards the adoption of new technologies in the healthcare sector in the region. Europe also held a significant market share in 2020, which is expected to increase during the forecast period due to the robust medical infrastructure and high diagnostic and care rates in Western Europe and technological advancements.
The Asia Pacific region is also expected to witness a robust growth in the coming years. Factors that contribute to the growth of the smart pills industry in the Asia Pacific include the large population base, the presence of small companies in China and Japan, the rise in people's disposable incomes, technological development, and an increasing trend in research in academic organisations in the area.
Smart pills, variously known as digital pills, are drugs administered to patients who are fitted with edible electronic sensors that transmit wireless signals to devices, such as patches, tablets, or smartphones, outside the body when they are swallowed.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The disease indications considered in the market can be divided into the following:
The target area can be segmented as follows:
Smart pills find wide applications in the following segments:
The end-uses for the product include:
The regional markets for smart pills can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The rise in the number of people suffering from gastrointestinal disorders would have a positive effect on the growth of the market over the projected period. Gastrointestinal, pancreatic, and liver disorders are a key source of substantial mortality, morbidity, and stress on the healthcare system throughout the globe. The high prevalence of liver and gastrointestinal diseases has led to a significant amount of pressure on the healthcare system, boosting the market growth. Other factors driving the growth of the market include the rising population, growing disposable incomes, and the growing medical sector.
The report gives a detailed analysis of the following key players in the global smart pills market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Indication |
|
Breakup by Applications |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Smart Pills Market Overview
3.1 Global Smart Pills Market Historical Value (2017-2023)
3.2 Global Smart Pills Market Forecast Value (2024-2032)
4 Global Smart Pills Market Landscape
4.1 Global Smart Pills Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Smart Pills Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Indications
4.2.3 Analysis by End User
5 Global Smart Pills Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Smart Pills Market Segmentation
6.1 Global Smart Pills Market by Type
6.1.1 Market Overview
6.1.2 Single Parameter Monitoring
6.1.3 Multiparameter Monitoring
6.2 Global Smart Pills Market by Indication
6.2.1 Market Overview
6.2.2 Occult GI Bleeding
6.2.3 Crohn’s Disease
6.2.4 Small Bowel Tumors
6.2.5 Celiac Disease
6.2.6 Inherited Polyposis Syndromes
6.2.7 Mental Disorders
6.2.8 Others
6.3 Global Smart Pills Market by Applications
6.3.1 Market Overview
6.3.2 Capsule Endoscopy
6.3.3 Drug Delivery
6.3.4 Patient Monitoring
6.3.5 Others
6.4 Global Smart Pills Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Diagnostic Centers
6.4.4 Research Institutes
6.4.5 Others
6.5 Global Smart Pills Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Smart Pills Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Smart Pills Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Smart Pills Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Smart Pills Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Smart Pills Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 CapsoVision, Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Olympus Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Medtronic Plc
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Koninklijke Philips N.V.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Proteus Digital Health, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
18 Global Smart Pills Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
In 2023, the global market for smart pills attained a value of USD 1.07 billion.
The market is anticipated to grow at a CAGR of 16.2% during the forecast period of 2024-2032 to reach a value of USD 4.13 billion by 2032.
The growth of the market is being driven by factors like rising population, growing disposable incomes, growing number of people suffering from gastrointestinal disorders, technological advancements, rising geriatric population, increasing disease complexity, and the thriving healthcare sector.
The rising cases of health disorders and growing investments into the healthcare sector are the key industry trends driving the market growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading disease indications in the market are oesophageal diseases, colon diseases, and small bowel diseases, among others.
The major target areas of smart pills in the industry are large intestine, small intestine, stomach, and oesophagus, among others.
The significant application segments in the market are capsule endoscopy, patient monitoring, and drug delivery, among others.
The leading end use sectors in the industry are diagnostic centres, hospitals, and research institutes, among others.
The major players in the industry are CapsoVision, Inc., Olympus Corporation, Medtronic Plc, Koninklijke Philips N.V., and Proteus Digital Health, Inc., among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.